Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. （開啟新視窗）

Boone JD, Kim KH, Marques M, Straughn JM.

來源‎: Gynecol Oncol 2014;132(1):227-30.

檢索‎: PubMed 24512847

DOI碼‎: 10.1016/j.ygyno.2013.10.019

https://www.ncbi.nlm.nih.gov/pubmed/24512847 （開啟新視窗）

Liberal or restrictive transfusion in high-risk patients after hip surgery. （開啟新視窗）

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators.

來源‎: N Engl J Med 2011;365(26):2453-62.

檢索‎: PubMed 22168590

DOI碼‎: 10.1056/NEJMoa1012452

https://www.ncbi.nlm.nih.gov/pubmed/22168590 （開啟新視窗）

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. （開啟新視窗）

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

來源‎: Transfusion 2016;56(10):2438-42.

檢索‎: PubMed 27385671

DOI碼‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 （開啟新視窗）

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. （開啟新視窗）

Ford PA, Grant SJ, Mick R, Keck G.

來源‎: J Clin Oncol 2015;33(15):1674-9.

檢索‎: PubMed 25870085

DOI碼‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 （開啟新視窗）

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. （開啟新視窗）

Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S.

來源‎: Transfus Med Rev 2002;16(1):34-45.

檢索‎: PubMed 11788928

https://www.ncbi.nlm.nih.gov/pubmed/11788928 （開啟新視窗）

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. （開啟新視窗）

Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

來源‎: N Engl J Med 1999;340(6):409-17.

檢索‎: PubMed 9971864

DOI碼‎: 10.1056/NEJM199902113400601

https://www.ncbi.nlm.nih.gov/pubmed/9971864 （開啟新視窗）

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? （開啟新視窗）

Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, Enamorado J, Arellano-Orden V.

來源‎: Intensive Care Med 2013;39(3):445-53.

檢索‎: PubMed 23184038

DOI碼‎: 10.1007/s00134-012-2757-z

https://www.ncbi.nlm.nih.gov/pubmed/23184038 （開啟新視窗）

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. （開啟新視窗）

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

來源‎: Cancer Treat Rev 2016;46:1-8.

檢索‎: PubMed 27046422

DOI碼‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 （開啟新視窗）

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. （開啟新視窗）

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

來源‎: Transfusion 2014;54(10 Pt 2):2678-86.

檢索‎: PubMed 25135770

DOI碼‎: 10.1111/trf.12825

https://www.ncbi.nlm.nih.gov/pubmed/25135770 （開啟新視窗）

Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. （開啟新視窗）

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D

來源‎: J Clin Oncol 2020;38(13):1463-73.

檢索‎: PubMed 32083994

DOI碼‎: 10.1200/JCO.19.01836

https://www.ncbi.nlm.nih.gov/pubmed/32083994 （開啟新視窗）

Transfusion indications for patients with cancer. （開啟新視窗）

Watkins T, Surowiecka MK, McCullough J.

來源‎: Cancer Control 2015;22(1):38-46.

檢索‎: PubMed 25504277

https://www.ncbi.nlm.nih.gov/pubmed/25504277 （開啟新視窗）

Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. （開啟新視窗）

Wehry J, Agle S, Philips P, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RC.

來源‎: Am J Surg 2015;210(6):1197-204.

檢索‎: PubMed 26602534

DOI碼‎: 10.1016/j.amjsurg.2015.08.013

https://www.ncbi.nlm.nih.gov/pubmed/26602534 （開啟新視窗）